Platelet activation factor (PAF)-,
ADP and
vasopressin-induced increments of platelet Ca2+ concentration were measured by
quin-2 in 64 patients with
essential hypertension and 16 normal donors. Basal concentration of free Ca2+ was 87 +/- 4 nM in donors, 106 +/- 5 nM in patients with labile
hypertension (LH) and 122 +/- 6 nM in those with stable
hypertension (SH) (p less than 0.01). PAF,
ADP and
vasopressin, added to platelets, increased [Ca]in by 448 +/- 58, 397 +/- 66, and 277 +/- 50 nM, respectively, in the donors, by 473 +/- 57, 479 +/- 54 and 195 +/- 32 nM, in LH patients, and by 607 +/- 85, 584 +/- 73 and 245 +/- 41 nM in SH patients. There were no significant variations between the three samples, using the ANOVA test. In 20 patients, whose both parents had
essential hypertension, [Ca]in increment was 738 +/- 8 nM for PAF, 682 +/- 90 nM for
ADP, and 320 +/- 61 nM for
vasopressin. In 19 patients, who admitted to no
essential hypertension in the family, these parameters were significantly lower: 310 +/- 40 nM for PAF, 389 +/- 61 nM for
ADP, and 147 +/- 26 nM for
vasopressin. The demonstrated changes may be making an important contribution to the maintenance of elevated vascular tone and provide an evidence in favor of a genetically-predetermined EH variety.